Pan Xiaoyu, Yue Lin, Ban Jiangli, Ren Lin, Chen Shuchun
Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People's Republic of China.
Department of Endocrinology, Hebei General Hospital, Shijiazhuang, People's Republic of China.
J Inflamm Res. 2022 Nov 24;15:6409-6425. doi: 10.2147/JIR.S391859. eCollection 2022.
Using proteomics to study the effect of semaglutide on cardiac protein expression in obese mice. Assessment of the effect of semaglutide on cardiac function in obese mice.
The mice were randomly divided into three groups: the control group (WC), the high-fat group (WF), and the high-fat diet with semaglutide intervention group (WS). Serum samples were collected, and lipids, blood glucose, inflammatory and oxidative stress markers, and cardiac ultrasound, were examined. The cardiac weight of each group of mice was measured, and pathological alterations were examined. Inflammation and oxidative stress levels in heart tissue were evaluated. The labeling coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) platform was used to find differentially expressed proteins (DEPs) and screen for related pathways and key proteins in a proteomics study.
Semaglutide greatly alleviated obesity-induced lipid metabolism abnormalities, improved cardiac ventricular wall thickening, and significantly reduced myocardial collagen content in obese mice. Semaglutide significantly reduces obesity-induced inflammation and oxidative stress. There were 64 DEPs in the WF/WC group, with 39 upregulated proteins and 25 downregulated proteins. The WS/WC group, on the other hand, had 83 DEPs, including 57 upregulated and 26 downregulated proteins. Following functional analysis, DEPs were shown to be largely associated with lipid metabolism and peroxisomes. Apolipoprotein A-II, catalase, diazepam-binding inhibitor, paraoxonase-1, and hydroxysteroid 17-dehydrogenase-4 were all upregulated in the WF group but significantly downregulated in the WS group. A high-fat diet increases the expression of lipid synthesis and transport proteins while increasing inflammation and oxidative stress damage.
Semaglutide decreases lipid synthesis alleviates inflammation and oxidative stress and prevents lipid peroxidation and cardiac impairment.
运用蛋白质组学研究司美格鲁肽对肥胖小鼠心脏蛋白质表达的影响。评估司美格鲁肽对肥胖小鼠心脏功能的作用。
将小鼠随机分为三组:对照组(WC)、高脂组(WF)和高脂饮食加司美格鲁肽干预组(WS)。采集血清样本,检测血脂、血糖、炎症和氧化应激标志物,并进行心脏超声检查。测量每组小鼠的心脏重量,检查病理改变。评估心脏组织中的炎症和氧化应激水平。在蛋白质组学研究中,使用液相色谱 - 串联质谱(LC-MS/MS)平台进行标记,以发现差异表达蛋白(DEP)并筛选相关途径和关键蛋白。
司美格鲁肽极大地缓解了肥胖诱导的脂质代谢异常,改善了心脏心室壁增厚,并显著降低了肥胖小鼠的心肌胶原含量。司美格鲁肽显著降低了肥胖诱导的炎症和氧化应激。WF/WC组有64个DEP,其中39个蛋白上调,25个蛋白下调。另一方面,WS/WC组有83个DEP,包括57个上调和26个下调蛋白。功能分析表明,DEP主要与脂质代谢和过氧化物酶体相关。载脂蛋白A-II、过氧化氢酶、地西泮结合抑制剂、对氧磷酶-1和羟类固醇17-脱氢酶-4在WF组均上调,但在WS组显著下调。高脂饮食会增加脂质合成和转运蛋白的表达,同时增加炎症和氧化应激损伤。
司美格鲁肽减少脂质合成,减轻炎症和氧化应激,预防脂质过氧化和心脏损伤。